These immune complexes activate platelets via FcγRIIa binding, resulting in thrombocytopenia and platelet activation (see Pathogenesis of thrombosis and thrombocytopenia in anti‐PF4 disorders). The gene discussed is PF4; the disease is deep vein thrombosis.